Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: shortness of breath major surgical or invasive procedure: intubation self-extubation intubation extubation intubation/mechanical ventilation history of present illness: 63 y/o man with a pmhx of copd on home o2(1.5-2l) & schizophrenia who was presented to the ed with complaint of cough, shortness of breath for 2 days. additional history is unclear, as the patient was noted to be a poor historian, but according to the medical records, the pt was recently hospitalized for copd exacerbation (discharged on and again on ). he has recently been treated with azithromycin, levoquin and completed a prednisone taper on . he was last seen by his pcp , at which time he appeared to be doing well and without complaints. . in the ed this evening, vitals were initially bp 121/61, hr 111, rr 34, sating 81% on room air. he recieved solumedrol, vancomycin and levoquin. he was noted to have worsening respiratory status and was placed on a non-rebreather. he subsequently was noted to be more lethargic, placed on bi-pap and then intubated. his bp dropped following intubation and the patient was given 4l ns and was started on levophed at .03 and transferred to the . . here, the patient is intubated, sedated, non-arousable on fentanyl and versed. additional history was unobtainable. past medical history: 1) copd: fev/fvc 60% in (no recent pfts available), on home 1.5-2l o2 at night only 2) secondary pulmonary hypertension (51-66 mm hg on echo ) 3) schizophrenia 4) hx gi bleeding 5) mental retardation social history: lives in with brother and brother-in-law. on disability since for mental health issues. visiting nurse twice daily. ongoing tobacco use, in the past as much as 4 packs/day. denies ongoing etoh or drug use. family history: non-contributory physical exam: vss, sat >90% on 2l nasal canula gen: nad, well developed middle aged male, poor eye contact : anicteric, reactive neck: supple, no lymphadenopathy, no thyromegaly pulm: very poor air movement, but clear bilaterally card: distant heart sounds, rrr by pulse, no m/r/g appreciated abd: bs+, soft, mildly distended ext: 2+ radial and pedal pulses. no clubbing, cyanosis or edema, shin bruising on left leg skin: hairless legs, vericose veins bilateral shins, extensive nail thickening bilateral toes. neuro/psych: poor eye contact, rambling speech but will answer direct questions appropriately pertinent results: chest (portable ap) study date of : single ap supine bedside chest radiograph: et tube is in satisfactory position, approximately 6 cm above the carina and at the level of the lower border of the clavicles. ng tube descends below the diaphragm with tip not visualized. there is worsening aeration, with increasing patchy consolidation in the right, middle, and lower lobes, which may represent an infection or aspiration. the left lung remains clear. no pneumothorax. impression: et tube in satisfactory position. worsening right middle and lower lung zone infiltrates, which could represent infection or aspiration. chest (portable ap) study date of : portable ap chest radiograph: ng tube follows appropriate course. et tube tip terminates 74 mm above the carina. right-sided central line with tip terminating in mid svc. worsening of opacities in both lung bases, that could represent area of aspiration pneumonia. cardiomediastinal silhouette is unremarkable. chest (portable ap) study date of : findings: endotracheal tube terminates about 5.7 cm above the carina. other indwelling devices remain in standard positions. cardiomediastinal contours are within normal limits. multifocal patchy parenchymal opacities in the right mid and both lower lungs appear slightly improved. findings may be due to provided history of pneumonia. differential diagnosis includes asymmetrical pattern of pulmonary edema in the setting of copd. admission laboratory results: 08:30pm blood wbc-17.0* rbc-4.86 hgb-15.3 hct-44.5 mcv-92 mch-31.5 mchc-34.4 rdw-12.7 plt ct-368 08:30pm blood neuts-89.5* lymphs-7.4* monos-2.9 eos-0.1 baso-0.1 08:30pm blood pt-14.2* ptt-34.2 inr(pt)-1.2* 08:30pm blood glucose-135* urean-20 creat-1.2 na-138 k-4.5 cl-98 hco3-30 angap-15 08:30pm blood calcium-9.1 phos-4.1 mg-1.7 09:58pm blood type-art temp-37.5 rates-/30 po2-323* pco2-79* ph-7.17* caltco2-30 base xs--1 discharge laboratory results: 4:24 am mrsa screen source: nasal swab. **final report ** mrsa screen (final ): positive for methicillin resistant staph aureus. blood gas results: 09:58pm blood type-art temp-37.5 rates-/30 po2-323* pco2-79* ph-7.17* caltco2-30 base xs--1 08:31am blood type-art rates- tidal v-500 peep-5 fio2-30 po2-76* pco2-60* ph-7.35 caltco2-35* base xs-4 -assist/con intubat-intubated 03:21pm blood type-art temp-36.7 rates-/22 tidal v-350 peep-5 fio2-30 po2-82* pco2-53* ph-7.38 caltco2-33* base xs-4 intubat-intubated vent-spontaneou 06:35pm blood type-art temp-36.7 rates-/30 fio2-35 po2-92 pco2-51* ph-7.40 caltco2-33* base xs-4 intubat-not intuba microbiology: urine urine culture-final (no growth) sputum gram stain-final; respiratory culture-final {mrsa} mrsa screen mrsa screen-final {positive for methicillin resistant staph aureus} sputum gram stain-final; respiratory culture-final {yeast}; legionella culture-final; fungal culture-preliminary {yeast, penicillium species} blood culture blood culture, routine-final (no growth) blood culture blood culture, routine-final (no growth) mrsa screen mrsa screen-final {positive for methicillin resistant staph aureus} urine urine culture-final (no growth) blood culture blood culture, routine-final (no growth) blood culture blood culture, routine-final (no growth) brief hospital course: # hypercarbic respiratory distress/tachypnea: pt with a history of copd and recent hospitalizations for exacerbation/pneumonia. given this history and his ct findings, it is likely that his initial presentation of dyspnea, cough, leukocytosis were similar to his previous complaints. his rapid respiratory decline upon presentation, however, is possibly due to increased supplemental o2 and a subsequent deminished respiratory drive. pco2 has been in the 50's at basline per previous abgs. patient was initiated on vancomycin, levofloxacin, and iv solumedrol at presentation. throughout the micu course, the patient was switched from iv solumedrol to oral prednisone on and a taper was begun. the dose of prednisone was 10 mg starting on prior to transfer out of the intensive care unit. patient remained intubated from admission until self-extubation on . he showed signs of hypercarbia on his arterial blood gas and was put on bipap; however, he evetually required intubation again early in morning of . he was then diuresed with > 2l negative fluid balance on prior to extubation. his sedation was lightened and he was extubated on afternoon of with blood gas of 7.40/51/92 on face mask with 35% fio2 several hours after extubation. later in the evening of he had abg on room air was 7.42/49/74. the patient's repiratory status continued to improve throughout his hospitalization and he was discharged to pulmonary rehab. his prednisone can continue to be tapered as an outpatient, with 20 mg po qday until , then 10 mg po qday thru and then discontinue. . # hypotension/hypertension: patient required levophed for sbps in the 80's s/p intubation on . hypotension was not fluid responsive and was likely induced by sedation required for intubation. alternatively, may have been hypovolemic due to recent illness or septic like picture in the setting of his pulmonary infection. patient was liberated from support with levophed on morning of . he then had hypertension starting on that required prns of iv hydralazine and furosemide iv. these episode of hypertension tended to correlate with sedation being lightened while patient was intubated. concern was raised that his hypertension to the 200s systolic prior to extubation on would lead to flash pulmonary edema, thus he was transiently on a nitro drip on following extubation. after extubation, he continued to be mildly hypertensive 150's-160's. po hydralazine was started and titrated up. on the medical floor, the patient's hydralazine was discontinued and his blood pressures remained within an acceptable range. . # leukocytosis: the patient had a persistent and increasing leukocytosis during his hospital admission. at 22k on , further infectious work-up was performed and unremarkable. wbc back down to 15k on discharge. . # hyperglycemia: no history of diabetes, though had some hyperglycemia thought to be due to steroids and was started on nph while in the micu. as his steroid dosing was tapered off, he began having several fsbg values that were in the 50s and 60s, his insulin was discontinued and fsbg values were measured for one additional day. . # schizophrenia/mr: pt apparently well functioning despite disability. per report of case manager, he is the most functional person in his household and takes care of the bills. no active issues with schizophrenia during this hospitalization. we continued zyprexa 5 mg qd. medications on admission: albuterol sulfate 2 puffs q 4 hrs prn fluticasone-salmeterol 1 puff atrovent 2 puffs four times a day olanzapine 5 mg qd omeprazole - 20 mg qd spiriva 1 capsule qd aspirin - 81 mg tablet qd home oxygen 2 liters nasal canula at bedtime. discharge medications: 1. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 2. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 3. olanzapine 5 mg tablet sig: one (1) tablet po daily (daily). 4. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) inhalation q4h (every 4 hours). 5. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 6. miconazole nitrate 2 % powder sig: one (1) appl topical (2 times a day). 7. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 8. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 9. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 10. prednisone 20 mg tablet sig: one (1) tablet po daily (daily): until , then decrease to 10 mg po qday x 4 days then discontinue. discharge disposition: extended care facility: & rehab center - discharge diagnosis: copd exacerbation, acute hypercarbic hypoxemic respiratory failure mrsa pneumonia leukocytosis, resolved discharge condition: vital signs stable discharge instructions: hospitalized for respiratory failure secondary to severe copd and pneumonia. discharged to for pulmonary rehabilitation. return to ed if having significant sob, high fevers, confusion, chills, rigors or increasing shortness of breath. followup instructions: provider: , m.d. phone: date/time: 9:40 provider: function lab phone: date/time: 9:40 provider: ,interpret w/lab no check-in intepretation billing date/time: 10:00 procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more insertion of endotracheal tube insertion of endotracheal tube arterial catheterization diagnoses: acidosis unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use acute kidney failure, unspecified unspecified septicemia obstructive chronic bronchitis with (acute) exacerbation sepsis unspecified schizophrenia, unspecified acute respiratory failure other specified cardiac dysrhythmias leukocytosis, unspecified other abnormal glucose unspecified intellectual disabilities other dependence on machines, supplemental oxygen methicillin resistant pneumonia due to staphylococcus aureus 

Answer: The patient is high likely exposed to